SS Innovations International (SSII) Convertible Debt (2023 - 2024)
SS Innovations International recorded quarterly Convertible Debt of $58144.0 in Q3 2024, up 71.35% quarter-over-quarter from $33933.0 in Q4 2023.
SS Innovations International's Convertible Debt history runs 2 years deep, the most recent figure standing at $58144.0 for Q3 2024.
- In Q3 2024, Convertible Debt changed N/A year-over-year to $58144.0; the TTM figure through Sep 2024 stood at $58144.0 (changed N/A YoY), while the FY2023 annual figure was $33933.0, changed N/A from the prior year.
- Convertible Debt came in at $58144.0 for Q3 2024 at SS Innovations International, up from $33933.0 in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $58144.0 in Q3 2024 to a low of $33933.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 58,144.00 |
| Dec 31, 2023 | 33,933.00 |